An Investigation Into the Efficacy of Herpecin L at Reducing the Frequency and Severity of Cold Sores

An Investigation Into the Efficacy of Herpecin L at Reducing the Frequency and Severity of Cold Sores

Focus Consumer Healthcare has developed Herpecin L. Herpecin L combines many different ingredients hypothesized to promote quick healing and symptom reduction from cold sores.

Inclusion Criteria:

• Male Female between 18-60 years of age.
• Must be in good health with no significant chronic conditions and a BMI under 35.
• Must experience regular cold sores or fever blisters
• Must agree to avoid daily lip balm or another product designed to alleviate their cold sore (e.g., Abreva or other over-the-counter cold sore products).

Exclusion Criteria:

• Suffers from pre-existing conditions that would prevent them from adhering to the protocol including chronic conditions such as oncological or psychiatric disorders.
• Anyone with known severe allergic reactions.
• Unwilling to follow the study protocol.
• Currently pregnant, breastfeeding, or wanting to become pregnant for the duration of the study.